Postdoctoral Scientist - Neuroinflammation
at University of Oxford
Oxford, England, United Kingdom -
Start Date | Expiry Date | Salary | Posted On | Experience | Skills | Telecommute | Sponsor Visa |
---|---|---|---|---|---|---|---|
Immediate | 18 Jan, 2025 | GBP 46913 Annual | 19 Oct, 2024 | N/A | Good communication skills | No | No |
Required Visa Status:
Citizen | GC |
US Citizen | Student Visa |
H1B | CPT |
OPT | H4 Spouse of H1B |
GC Green Card |
Employment Type:
Full Time | Part Time |
Permanent | Independent - 1099 |
Contract – W2 | C2H Independent |
C2H W2 | Contract – Corp 2 Corp |
Contract to Hire – Corp 2 Corp |
Description:
APPLICATION PROCESS
The post is full time and fixed-term for 3 years
Applications for this vacancy are to be made online. You will be required to upload a supporting statement and CV as part of your online application. The supporting statement should include a cover letter and should also clearly describe how you meet each of the selection criteria listed in the job description. Click here for more information and advice on how to write an effective supporting statement.
Only applications received before 12:00 midday on 30/10/2024 will be considered. Interviews will be held as soon as possible thereafter
Responsibilities:
An exciting opportunity to join a multidisciplinary research team at the Oxford centre for Neuroinflammation.
You are invited to apply to join Professor Lars Fugger and his team at the MRC Translational Discovery Immunology Unit, based at the Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford. You will join a team of research scientists, computational biologists, and clinicians, have access to state-of-the-art technologies and collaborate with leading researchers both locally and globally.
This research project aims to explore the role of immune cells from patients with multiple sclerosis (MS) at different stages of disease and to understand how they interact with cells of the central nervous system (CNS). Using innovative techniques this research aims to expose new disease-associated immune cell populations and reinforce how environmental context is critical to their phenotype and subsequent role in disease. Our incomplete understanding of the causes and pathways involved in the onset and progression of MS limits our ability to effectively diagnose and treatment patients and therefore this research aims to be clinically translatable and aid drug development.
REQUIREMENT SUMMARY
Min:N/AMax:5.0 year(s)
Hospital/Health Care
Pharma / Biotech / Healthcare / Medical / R&D
Health Care
Graduate
Proficient
1
Oxford, United Kingdom